Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tracking Alzheimerʼs disease in transgenic mice using fluorodeoxyglucose autoradiography

1 Apr 2000

Abstract excerpt

While transgenic mice have great promise in the study of Alzheimer's disease (AD), uncertainties remain about the extent to which they provide a model of the disorder or the best way to characterize disease progression. Using fluorodeoxyglucose (FDG) autoradiography, we found that transgenic mice over-expressing a mutant form of the human amyloid precursor protein have preferentially and progressively reduced...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Functional Brain Connectivity Studies
Share to Neuroscience and Neuropharmacology Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10790869
DOI: 10.1097/00001756-200004070-00018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tracking Alzheimerʼs disease in transgenic mice using fluorodeoxyglucose autoradiographyPMID 10790869Read ↗

FDG autoradiography reveals developmental and pathological effects of mutant amyloid in PDAPP transgenic mice.Semantic proximity Read ↗

Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease.Semantic proximity Read ↗

Transgenic mice and modeling Alzheimer's disease.Semantic proximity Read ↗

Transgenic animals relevant to Alzheimer’s diseaseSemantic proximity Read ↗

Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using 18F-FDG-PET.Semantic proximity Read ↗

MicroPET imaging and transgenic models: a blueprint for Alzheimer's disease clinical researchSemantic proximity Read ↗

Presenilin transgenic mice as models of Alzheimer’s diseaseSemantic proximity Read ↗

A decade of modeling Alzheimer's disease in transgenic miceSemantic proximity Read ↗

Differential Effects of Human P301L Tau Expression in Young versus Aged Mice.Semantic proximity Read ↗

Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse ModelsSemantic proximity Read ↗

Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease.Semantic proximity Read ↗

Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.